March 4–8, 2019
Alexandria, VA, USA
Meet Genedata Expressionist experts at the 10th Biotherapeutics Analytical Summit in Alexandria, VA, USA.
Don't miss the opportunity to see how Genedata solutions efficiently support the whole biopharmaceutical R&D workflow, including screening and protein engineering, expression and purification, characterization and analysis of protein therapeutics, cell line design and development, bioprocess optimization, and quality control of biologicals.
To get more information about Genedata solutions, please contact email@example.com
Automating Data Analysis for the Characterization of Biotherapeutics Candidates
Daniela Tomazela, PhD, Merck, Palo Alto, CA, USA
Advances in Characterization Methods & Approaches Stream
Tuesday, March 5 | 3:20–3:50 pm
As part of discovery-developability, sequence-variant evaluation and analysis of stressed samples are critical steps on the path toward final candidate selection. The diverse and large volumes of data generated during the evaluation of molecules’ intactness, sequence coverage, and potential liabilities makes producing reports cumbersome and time-consuming. In this talk, we will focus on MS analysis of biotherapeutic candidates to demonstrate an implementation of data analysis automation in support of early-discovery.
Automated Data Processing and Analysis for Quality Monitoring of Biotherapeutics by Multi-attribute Method (MAM)
An Automated Approach for Comprehensive Characterization and Quantification of Low-abundance Sequence Variants in a Standard Monoclonal Antibody